Greedy Insider
ARTV Insider Trades and Greediness Scores
Artiva Biotherapeutics, Inc. (ARTV) insider trades: since Dec 15, 2025, Greedy Insider recorded 22 open-market buys and 22 sales on Form 4 from 7 insiders. The strongest recent filing scored 87 (Strong).
Who bought and who sold
Across the last 44 scoreable Form 4 transactions in ARTV, 22 were open-market purchases and 22 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.
| Insider | Role | Type | Shares | Date | Score | ||
|---|---|---|---|---|---|---|---|
| Aslan Fred | CEO | Sell | 23463.0 | 168879.64 | 2026-10-06 | 76 | View |
| Aslan Fred | CEO | Sell | 61696.0 | 421827.9 | 2026-10-05 | 83 | View |
| Bush Jennifer | COO, CLO, Compliance Officer | Sell | 8370.0 | 57227.363 | 2026-10-05 | 79 | View |
| Banerjee Subhashis | Chief Medical Officer | Sell | 1099.0 | 7514.083 | 2026-10-05 | 70 | View |
| Horan Christopher | Chief Tech Operations Officer | Sell | 10340.0 | 70696.65 | 2026-10-05 | 80 | View |
| Aslan Fred | CEO | Sell | 23429.0 | 255746.28 | 2026-09-08 | 79 | View |
| Banerjee Subhashis | Chief Medical Officer | Sell | 1100.0 | 12271.16 | 2026-09-03 | 72 | View |
| Aslan Fred | CEO | Sell | 61888.0 | 690391.56 | 2026-09-03 | 87 | View |
| Horan Christopher | Chief Tech Operations Officer | Sell | 10366.0 | 115637.914 | 2026-09-03 | 84 | View |
| Bush Jennifer | COO, CLO, Compliance Officer | Sell | 8391.0 | 93605.8 | 2026-09-03 | 83 | View |
The strongest recent filing
Aslan Fred (CEO) sold 61,888 shares of Artiva Biotherapeutics, Inc. on Sep 3, 2026, a filing that scored 87 (Strong). It scored Strong because a senior insider was trading and it was direct personal ownership. The score describes the filing, not future returns. This is not investment advice.
Cluster activity
A cluster buy is present: 4 insiders (Aslan Fred, Banerjee Subhashis, Horan Christopher, Bush Jennifer) traded ARTV the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.
How this compares with Artiva Biotherapeutics, Inc.'s own history
Open-market buys make up 50% of the 44 scoreable ARTV transactions on record between Dec 15, 2025 and Oct 6, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.
Methodology and sources
Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.
Key facts
- Scoreable Form 4 transactions on record: 44
- Open-market buys: 22
- Sales: 22
- Distinct insiders: 7
- Strongest recent Greediness Score: 87 (Strong)
Primary sources
Related
- Strongest filing
- ARTV in the live feed
- How the Greediness Score works
- What is a cluster buy?
- Form 4 transaction codes
The score describes the filing, not future returns. This is not investment advice.